View in EDS

Time-to-pregnancy in patients with previous breast cancer and unexposed women: a prospective exposed-unexposed cohort study.

Saved in:
Bibliographic Details
Title: Time-to-pregnancy in patients with previous breast cancer and unexposed women: a prospective exposed-unexposed cohort study.
Authors: Hamy AS; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France., Chabassier A; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France., Sebbag C; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France., Rousset-Jablonski C; Centre Léon Bérard, Lyon, France.; RESearch on HealthcAre PErformance (RESHAPE), University Claude Bernard Lyon 1, Lyon, France., Berkach C; Unité de Génétique Clinique, Hôpital Saint-Louis, APHP, France., Ray-Coquard I; Centre Léon Bérard, Lyon, France.; RESearch on HealthcAre PErformance (RESHAPE), University Claude Bernard Lyon 1, Lyon, France., Sablone L; Seintinelles Research Network, 40 Rue Rémy Dumoncel, Paris, 75014, France., Darrigues L; Department of Surgical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France., Dumas E; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France., Bobrie A; Department of Medical Oncology, Institut du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France., Jacot W; Department of Medical Oncology, Institut du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France., Espié M; Sénopole, Hôpital Saint-Louis, AP-HP, Paris, France.; Université Paris Cité, Paris, France., Giacchetti S; Sénopole, Hôpital Saint-Louis, AP-HP, Paris, France.; Université Paris Cité, Paris, France., Jochum F; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Department of Gynecology, Strasbourg University Hospital, Strasbourg, France., Toussaint A; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France., Plu-Bureau G; Department of Gynecology, Hôpital Cochin, Paris, France.; Université Paris Cité, Paris, France., Maitrot-Mantelet L; Department of Gynecology, Hôpital Cochin, Paris, France.; Université Paris Cité, Paris, France., Gompel A; Department of Gynecology, Hôpital Cochin, Paris, France.; Université Paris Cité, Paris, France., Gougis P; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Sorbonne Université, INSERM, UNICO-GRECO Cardio-oncology Program, Department of Pharmacology, GRC27, CIC-1901, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France., Bas R; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France., Decanter C; ART Department, Centre Hospitalier Régional Lille, Lille, France., Asselain B; Department of Biostatistics, Unicancer, Paris, France., Coutant C; Clinical Research Department, Centre Georges-François Leclerc (Unicancer), Dijon, France., Sohn L; Seintinelles Research Network, 40 Rue Rémy Dumoncel, Paris, 75014, France., Jacob G; Seintinelles Research Network, 40 Rue Rémy Dumoncel, Paris, 75014, France., Saule C; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France., Frank S; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France., Abécassis J; Project-team Soda, Inria Saclay, Palaiseau, France.; Institut Polytechnique de Paris, Palaiseau, France., Coussy F; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France., Reyal F; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Department of Surgical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.
Corporate Authors: Seintinelles Research Network
Source: EClinicalMedicine [EClinicalMedicine] 2025 Jul 30; Vol. 86, pp. 103392. Date of Electronic Publication: 2025 Jul 30 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40777863
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Time-to-pregnancy in patients with previous breast cancer and unexposed women: a prospective exposed-unexposed cohort study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hamy+AS%22">Hamy AS</searchLink>; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Chabassier+A%22">Chabassier A</searchLink>; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Sebbag+C%22">Sebbag C</searchLink>; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Rousset-Jablonski+C%22">Rousset-Jablonski C</searchLink>; Centre Léon Bérard, Lyon, France.; RESearch on HealthcAre PErformance (RESHAPE), University Claude Bernard Lyon 1, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Berkach+C%22">Berkach C</searchLink>; Unité de Génétique Clinique, Hôpital Saint-Louis, APHP, France.<br /><searchLink fieldCode="AU" term="%22Ray-Coquard+I%22">Ray-Coquard I</searchLink>; Centre Léon Bérard, Lyon, France.; RESearch on HealthcAre PErformance (RESHAPE), University Claude Bernard Lyon 1, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Sablone+L%22">Sablone L</searchLink>; Seintinelles Research Network, 40 Rue Rémy Dumoncel, Paris, 75014, France.<br /><searchLink fieldCode="AU" term="%22Darrigues+L%22">Darrigues L</searchLink>; Department of Surgical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Dumas+E%22">Dumas E</searchLink>; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bobrie+A%22">Bobrie A</searchLink>; Department of Medical Oncology, Institut du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Jacot+W%22">Jacot W</searchLink>; Department of Medical Oncology, Institut du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Espié+M%22">Espié M</searchLink>; Sénopole, Hôpital Saint-Louis, AP-HP, Paris, France.; Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Giacchetti+S%22">Giacchetti S</searchLink>; Sénopole, Hôpital Saint-Louis, AP-HP, Paris, France.; Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Jochum+F%22">Jochum F</searchLink>; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Department of Gynecology, Strasbourg University Hospital, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Toussaint+A%22">Toussaint A</searchLink>; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Plu-Bureau+G%22">Plu-Bureau G</searchLink>; Department of Gynecology, Hôpital Cochin, Paris, France.; Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Maitrot-Mantelet+L%22">Maitrot-Mantelet L</searchLink>; Department of Gynecology, Hôpital Cochin, Paris, France.; Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Gompel+A%22">Gompel A</searchLink>; Department of Gynecology, Hôpital Cochin, Paris, France.; Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Gougis+P%22">Gougis P</searchLink>; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Sorbonne Université, INSERM, UNICO-GRECO Cardio-oncology Program, Department of Pharmacology, GRC27, CIC-1901, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bas+R%22">Bas R</searchLink>; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Decanter+C%22">Decanter C</searchLink>; ART Department, Centre Hospitalier Régional Lille, Lille, France.<br /><searchLink fieldCode="AU" term="%22Asselain+B%22">Asselain B</searchLink>; Department of Biostatistics, Unicancer, Paris, France.<br /><searchLink fieldCode="AU" term="%22Coutant+C%22">Coutant C</searchLink>; Clinical Research Department, Centre Georges-François Leclerc (Unicancer), Dijon, France.<br /><searchLink fieldCode="AU" term="%22Sohn+L%22">Sohn L</searchLink>; Seintinelles Research Network, 40 Rue Rémy Dumoncel, Paris, 75014, France.<br /><searchLink fieldCode="AU" term="%22Jacob+G%22">Jacob G</searchLink>; Seintinelles Research Network, 40 Rue Rémy Dumoncel, Paris, 75014, France.<br /><searchLink fieldCode="AU" term="%22Saule+C%22">Saule C</searchLink>; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Frank+S%22">Frank S</searchLink>; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Abécassis+J%22">Abécassis J</searchLink>; Project-team Soda, Inria Saclay, Palaiseau, France.; Institut Polytechnique de Paris, Palaiseau, France.<br /><searchLink fieldCode="AU" term="%22Coussy+F%22">Coussy F</searchLink>; Department of Medical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Reyal+F%22">Reyal F</searchLink>; Residual Tumor and Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Université Paris Cité, Paris, France.; Department of Surgical Oncology, Institut Curie, Paris, France.; Université Paris Cité, Paris, France.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Seintinelles+Research+Network%22">Seintinelles Research Network</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101733727%22">EClinicalMedicine</searchLink> [EClinicalMedicine] 2025 Jul 30; Vol. 86, pp. 103392. <i>Date of Electronic Publication: </i>2025 Jul 30 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22The+Lancet%22">The Lancet </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101733727 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2589-5370 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225895370%22">25895370 </searchLink><i>NLM ISO Abbreviation: </i>EClinicalMedicine <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40777863
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.eclinm.2025.103392
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 103392
    Titles:
      – TitleFull: Time-to-pregnancy in patients with previous breast cancer and unexposed women: a prospective exposed-unexposed cohort study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hamy AS
      – PersonEntity:
          Name:
            NameFull: Chabassier A
      – PersonEntity:
          Name:
            NameFull: Sebbag C
      – PersonEntity:
          Name:
            NameFull: Rousset-Jablonski C
      – PersonEntity:
          Name:
            NameFull: Berkach C
      – PersonEntity:
          Name:
            NameFull: Ray-Coquard I
      – PersonEntity:
          Name:
            NameFull: Sablone L
      – PersonEntity:
          Name:
            NameFull: Darrigues L
      – PersonEntity:
          Name:
            NameFull: Dumas E
      – PersonEntity:
          Name:
            NameFull: Bobrie A
      – PersonEntity:
          Name:
            NameFull: Jacot W
      – PersonEntity:
          Name:
            NameFull: Espié M
      – PersonEntity:
          Name:
            NameFull: Giacchetti S
      – PersonEntity:
          Name:
            NameFull: Jochum F
      – PersonEntity:
          Name:
            NameFull: Toussaint A
      – PersonEntity:
          Name:
            NameFull: Plu-Bureau G
      – PersonEntity:
          Name:
            NameFull: Maitrot-Mantelet L
      – PersonEntity:
          Name:
            NameFull: Gompel A
      – PersonEntity:
          Name:
            NameFull: Gougis P
      – PersonEntity:
          Name:
            NameFull: Bas R
      – PersonEntity:
          Name:
            NameFull: Decanter C
      – PersonEntity:
          Name:
            NameFull: Asselain B
      – PersonEntity:
          Name:
            NameFull: Coutant C
      – PersonEntity:
          Name:
            NameFull: Sohn L
      – PersonEntity:
          Name:
            NameFull: Jacob G
      – PersonEntity:
          Name:
            NameFull: Saule C
      – PersonEntity:
          Name:
            NameFull: Frank S
      – PersonEntity:
          Name:
            NameFull: Abécassis J
      – PersonEntity:
          Name:
            NameFull: Coussy F
      – PersonEntity:
          Name:
            NameFull: Reyal F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 07
              Text: 2025 Jul 30
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2589-5370
          Numbering:
            – Type: volume
              Value: 86
          Titles:
            – TitleFull: EClinicalMedicine
              Type: main
ResultId 1